FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.

: Until now, forkhead box P1 (FOXP1) has been identified as a tumor suppressor in several correlation studies in breast cancer. Although FOXP1 is defined as a transcriptional repressor that interacts with other transcription factors in various mechanistic studies, there is no study that explains its repressor functions in breast cancer biology. This study demonstrated the repressor function of FOXP1 on nuclear factor of activated T cells (NFAT1) and the migratory effect of this repression in MDA-MB-231 breast cancer cells. Co-immunoprecipitation experiments were performed for the investigation of protein-protein interaction between two transcription factors. Protein-protein interaction on DNA was investigated with EMSA and transcriptional effects of FOXP1 on NFAT1, luciferase reporter assay was performed. Wound healing assay was used to analyze the effects of overexpression of FOXP1 on tumor cell migration. This study showed that FOXP1 has protein-protein interaction with NFAT1 on DNA and enhances breast cancer cell migration by repressing NFAT1 transcriptional activity and FOXP1 shows oncogenic function by regulating breast cancer cell motility.

[1]  S. Fox,et al.  Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptorβ in primary invasive breast carcinomas , 2008, Breast Cancer Research and Treatment.

[2]  S. Yue,et al.  FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells. , 2014, Molecular medicine reports.

[3]  Xiaoyan Zhou,et al.  FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma , 2011, Annals of Hematology.

[4]  Haley O. Tucker,et al.  The transcription factor Foxp1 is a critical negative regulator of the differentiation of follicular helper T cells , 2014, Nature Immunology.

[5]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[6]  Shan-shan Wu,et al.  Depleting NFAT1 expression inhibits the ability of invasion and migration of human lung cancer cells , 2013, Cancer Cell International.

[7]  H. Aburatani,et al.  Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. , 2014, Molecular endocrinology.

[8]  A. Toker,et al.  NFAT Induces Breast Cancer Cell Invasion by Promoting the Induction of Cyclooxygenase-2* , 2006, Journal of Biological Chemistry.

[9]  Hui Wang,et al.  NFAT as cancer target: mission possible? , 2014, Biochimica et biophysica acta.

[10]  Bin Wang,et al.  Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation , 2004, Development.

[11]  K. Horie-Inoue,et al.  Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients , 2012, Hormones and Cancer.

[12]  Y. Hayashizaki,et al.  FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. , 2008, Biochemical and biophysical research communications.

[13]  A. Rosenwald,et al.  Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. , 2008, Blood.

[14]  A. Harris,et al.  Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1α expression , 2006, Modern Pathology.

[15]  A. Toker,et al.  NFAT promotes carcinoma invasive migration through glypican-6 , 2011, The Biochemical journal.

[16]  Giuseppe Garcea,et al.  Preoperative early warning scores can predict in-hospital mortality and critical care admission following emergency surgery. , 2010, The Journal of surgical research.

[17]  Y. Jeng,et al.  Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling , 2012, Oncogene.

[18]  R. Shui,et al.  Male breast carcinoma: a clinicopathological and immunohistochemical characterization study. , 2014, International journal of clinical and experimental pathology.

[19]  E. Lam,et al.  FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis , 2013, Cell Death and Differentiation.

[20]  H. Okamoto,et al.  Foxp1 and Lhx1 Coordinate Motor Neuron Migration with Axon Trajectory Choice by Gating Reelin Signalling , 2010, PLoS biology.

[21]  Ming Li,et al.  Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. , 2014, Cancer research.

[22]  F. Macian,et al.  NFAT proteins: key regulators of T-cell development and function , 2005, Nature Reviews Immunology.

[23]  Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma , 2012 .

[24]  Tae Hyong Kim,et al.  Integrin (α6β4) Signals Through Src to Increase Expression of S100A4, a Metastasis-Promoting Factor: Implications for Cancer Cell Invasion , 2009, Molecular Cancer Research.

[25]  S. Fox,et al.  Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers , 2009, Journal of Clinical Pathology.

[26]  Haikun Wang,et al.  Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells , 2011, Nature Immunology.

[27]  Philip Tucker,et al.  Multiple Domains Define the Expression and Regulatory Properties of Foxp1 Forkhead Transcriptional Repressors* , 2003, Journal of Biological Chemistry.

[28]  A. Toker,et al.  Akt/Protein Kinase B and Glycogen Synthase Kinase-3β Signaling Pathway Regulates Cell Migration through the NFAT1 Transcription Factor , 2009, Molecular Cancer Research.

[29]  C. Ballantyne,et al.  Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. , 2004, The Journal of clinical investigation.

[30]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[31]  C Fidler,et al.  The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. , 2001, Cancer research.

[32]  D. Dix,et al.  Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia , 2001, Cell stress & chaperones.

[33]  W. Neuhofer,et al.  NFAT5-mediated expression of S100A4 contributes to proliferation and migration of renal carcinoma cells , 2014, Front. Physiol..

[34]  F. Berthold,et al.  FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma , 2014, BMC Cancer.

[35]  A. Banham,et al.  FOXP1: a potential therapeutic target in cancer , 2007, Expert opinion on therapeutic targets.

[36]  S. Wong,et al.  Integrin αMβ2 Clustering Triggers Phosphorylation and Activation of Protein Kinase Cδ that Regulates Transcription Factor Foxp1 Expression in Monocytes , 2010, The Journal of Immunology.

[37]  S. Fox,et al.  Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast Carcinomas , 2004, Clinical Cancer Research.

[38]  Yun-jie Wang,et al.  NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells , 2013, PloS one.

[39]  Weiguo Shu,et al.  Characterization of a New Subfamily of Winged-helix/Forkhead (Fox) Genes That Are Expressed in the Lung and Act as Transcriptional Repressors* , 2001, The Journal of Biological Chemistry.

[40]  M. Wirth,et al.  Expression of the Forkhead Transcription Factor FOXP1 is Associated with Tumor Grade and Ki67 Expression in Clear Cell Renal Cell Carcinoma , 2011, Cancer investigation.

[41]  Tak W. Mak,et al.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum , 1998, Nature.

[42]  M. Pan,et al.  NFAT gene family in inflammation and cancer. , 2013, Current molecular medicine.

[43]  S. Grundmann,et al.  FoxP1 Stimulates Angiogenesis by Repressing the Inhibitory Guidance Protein Semaphorin 5B in Endothelial Cells , 2013, PloS one.

[44]  Wenyan Zhang,et al.  Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients , 2012, Medical Oncology.

[45]  Haley O. Tucker,et al.  Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18 , 2013, Development.

[46]  S. O. Halacli,et al.  FOXP1 regulation via the PI3K/Akt/p70S6K signaling pathway in breast cancer cells , 2015, Oncology letters.

[47]  Su In Lee,et al.  FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells , 2015, Oncotarget.

[48]  Anjana Rao,et al.  NFAT, immunity and cancer: a transcription factor comes of age , 2010, Nature Reviews Immunology.

[49]  Shanru Li,et al.  Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms. , 2010, Genes & development.

[50]  S. Fox,et al.  Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the Androgen receptor in prostate cancer but is not directly regulated by Androgens or hypoxia , 2007, The Prostate.

[51]  M. Li,et al.  FoxP1 promotes midbrain identity in embryonic stem cell‐derived dopamine neurons by regulating Pitx3 , 2010, Journal of neurochemistry.

[52]  J. Qin,et al.  Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell. , 2014, Experimental and molecular pathology.

[53]  G. Ippolito,et al.  Foxp1 is an essential transcriptional regulator for the generation of quiescent naive T cells during thymocyte development. , 2010, Blood.